Another meta-analysis looks at the existing studies and finds no evidence testosterone therapy increases thromboembolism. The abstract says:
"While regulatory bodies have warned about increased risk of venous thromboembolism (VTE), published clinical data supporting an increased risk for VTE are limited. Six RCTs (n = 2236) and 5 observational studies (n = 1,249,640) were included [in our analysis]. Five RCTs were performed in men with documented hypogonadism. The observational studies included: 2 case-control studies, 2 retrospective cohorts, and 1 retrospective cohort with a nested case-control study. There was no evidence of a statistically significant association between VTE and testosterone."
"While regulatory bodies have warned about increased risk of venous thromboembolism (VTE), published clinical data supporting an increased risk for VTE are limited. Six RCTs (n = 2236) and 5 observational studies (n = 1,249,640) were included [in our analysis]. Five RCTs were performed in men with documented hypogonadism. The observational studies included: 2 case-control studies, 2 retrospective cohorts, and 1 retrospective cohort with a nested case-control study. There was no evidence of a statistically significant association between VTE and testosterone."
